¶û°Ô¸£Çѽº ¼¼Æ÷ Á¶Á÷±¸ÁõÀÇ Ä¡·á °á°ú
Treatment Outcome of Langerhans Cell Histocytosis

´ëÇѰñ°üÀýÁ¾¾çÇÐȸÁö 2014³â 20±Ç 1È£ p.14 ~ p.21

Á¤¼ÒÇÐ(Chung So-Hak) - °í½Å´ëÇб³ Àǰú´ëÇÐ Á¤Çü¿Ü°úÇб³½Ç
±èÀçµµ(Kim Jae-Do) - °í½Å´ëÇб³ Àǰú´ëÇÐ Á¤Çü¿Ü°úÇб³½Ç
Á¶ÇöÀÍ(Cho Hyun-Ik) - °í½Å´ëÇб³ Àǰú´ëÇÐ Á¤Çü¿Ü°úÇб³½Ç

Abstract

¸ñÀû: º» ±³½Ç¿¡¼­ °æÇèÇÑ ¶û°Ô¸£Çѽº ¼¼Æ÷ Á¶Á÷±¸ÁõÀÇ ÀÓ»óÀû Ư¡À» ¾Ë¾Æº¸°í Ä¡·á¹æ¹ý ¹× ¿¹Èĸ¦ ¾Ë¾Æº¸°íÀÚ ÇÑ´Ù.

´ë»ó ¹× ¹æ¹ý: 1996³â 8¿ùºÎÅÍ 2013³â 6¿ù±îÁö º» ±³½Ç¿¡¼­ ¼ö¼ú ÈÄ ¶û°Ô¸£Çѽº ¼¼Æ÷ Á¶Á÷±¸ÁõÀ¸·Î È®Áø µÈ ÃÑ 28·Ê¸¦ ´ë»óÀ¸·Î ¹ßº´ ´ç½ÃºÎÅÍ ÃÖ±Ù±îÁöÀÇ ÁøÂû¼Ò°ß, Àǹ«±â·Ï, ¹æ»ç¼± »çÁø, º´¸®¼Ò°ßÀ» Åä´ë·Î ÀÓ»ó¼Ò°ß°ú Áø´Ü ¹× Ä¡·á°á°ú¿¡ ´ëÇØ ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù.

°á°ú: ÃÑ 28·Ê·Î ¼Ò¾Æ 22·Ê ¼ºÀÎ 6·Ê¿´´Ù. ¹ßº´³ªÀÌ´Â 0.6¼¼¿¡¼­ 51¼¼ »çÀÌ¿¡¼­ ¹ß»ýÇÏ¿´À¸¸ç Æò±Õ¿¬·ÉÀº 14.8¼¼¿´´Ù. Ã߽à ±â°£Àº 6°³¿ù¿¡¼­ 134°³¿ù±îÁö Æò±Õ 44.6°³¿ù À̾ú´Ù. ȯÀÚÀÇ ±¸¼ºÀº ³²ÀÚ 20¸í ¿©ÀÚ 8¸íÀ¸·Î ³²³à¼ººñ´Â 2.5:1À̾ú´Ù. ÃʱâÁõ»óÀº µ¿Åë 18·Ê, º´Àû °ñÀý 5·Ê, Á¾±« 3·Ê, ¹æ»ç¼± °Ë»ç»ó ¿ì¿¬È÷ ¹ß°ßµÈ °æ¿ì 1·Ê, »ç°æ 1·Ê¿´´Ù. ¹æ»ç¼±ÇÐÀû ¼Ò°ß¿¡¼­´Â ¸ðµç Áõ·Ê¿¡¼­ °ñ ¿ëÇØ ¼Ò°ßÀ» º¸¿´À¸¸ç ÀÌÁß 13·Ê¿¡¼­´Â °ñ¸· ¹ÝÀÀÀÌ µ¿¹ÝµÇ¾úÀ¸¸ç 1·Ê¿¡¼­´Â ¿¬ºÎÁ¶Á÷ ħ¹üÀÌ °üÂûµÇ¾ú´Ù. ÀÓ»óÀû ºÐ·ù·Î 28·Ê ¸ðµÎ È£»ê±¸¼º À°¾ÆÁ¾ À̾úÀ¸¸ç Á¶Á÷±¸ Çùȸ°¡ Á¦½ÃÇÑ ºÐ·ù¹ýÀ¸·Î´Â ´ÜÀϰèÅëÀÇ ´Ù¹ß º´¼Ò Áúȯ 3·Ê, ´ÜÀÏ º´¼Ò Áúȯ 25·Ê¿´´Ù. Àü·Ê¿¡¼­ Á¶Á÷ »ý°Ë¼úÀÌ ½ÃÇàµÇ¾úÀ¸¸ç 6·Ê¿¡¼­´Â »ý°Ë¼ú ÀÌÈÄ Æ¯º°ÇÑ Ä¡·á ¾øÀÌ °ñ À¯ÇÕÀ» ¾ò¾úÀ¸¸ç 11·Ê¿¡¼­´Â ½ºÅ×·ÎÀÌµå ±¹¼Ò ÁÖÀÔ¼úÀ» ½ÃÇàÇÏ¿´À¸¸ç 11·Ê´Â Á¶Á÷»ý°Ë°ú µ¿½Ã¿¡ ¼ÒÆÄ¼ú ¹× °ñ À̽ļúÀ» ½ÃÇàÇϰųª Ãß°¡·Î ±Ý¼Ó ³»°íÁ¤¼úÀ» ½ÃÇàÇÏ¿´´Ù. Ã߽ñⰣ Áß È¯ÀÚ°¡ »ç¸ÁÇÑ °æ¿ì´Â ¾ø¾ú´Ù. º´º¯ÀÌ ±¹¼Ò Àç¹ßÇÑ °æ¿ì´Â ¾ø¾úÀ¸³ª ½Åü ´Ù¸¥ ºÎÀ§¿¡ °ñº´º¯ÀÌ »ý±ä °æ¿ì°¡ 3·Ê ÀÖ¾ú´Ù. ÇÕº´ÁõÀº ÃÑ 2·Ê°¡ ÀÖ¾úÀ¸¸ç ¼ÒÆÄ¼ú ¹× °ñ À̽ļúÀ» ½ÃÇàÇÑ ÀÌÈÄ °¨¿°¼Ò°ßÀ» º¸¿© º¯¿¬ÀýÁ¦¼úÀ» ½ÃÇàÇÑ °æ¿ì¿´´Ù.

°á·Ð: ¶û°Ô¸£Çѽº ¼¼Æ÷ Á¶Á÷±¸Áõ ȯÀÚ¿¡¼­ ±Þ°ÝÇÑ Àü½ÅÀû ¹ßº´À» °¡Á®¿À´Â °æ¿ì´Â ¸Å¿ì µå¹°±â ¶§¹®¿¡ Ãʱâ Áø´Ü ½Ã¿¡ ¾î¸° ȯ¾Æ¿¡°Ô °úµµÇÑ ¹æ»ç¼± ³ëÃâÀ» °¡Á®¿À´Â °Ë»ç´Â Áö¾çÇØ¾ß ÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù. ÁúȯÀÇ È®ÁøÀ» À§Çؼ­´Â Á¶Á÷ »ý°ËÀÌ ÇÊ¿äÇϸç Á¶Á÷ÇÐÀû È®Áø ÀÌÈÄ¿¡´Â °æ°ú°üÂû¸¸À¸·Îµµ ´ëºÎºÐ¿¡¼­ ¸¸Á·½º·¯¿î °á°ú¸¦ ¾òÀ» ¼ö ÀÖÀ¸³ª ¼ú Àü º´Àû °ñÀýÀÌ Àְųª °ñ ÆÄ±« º´º¯ÀÇ ¹üÀ§°¡ ³ÐÀº °æ¿ì ¼ÒÆÄ¼ú ¹× °ñ À̽ļú°ú ³»°íÁ¤¼úÀÌ ÇÊ¿äÇÒ ¼öµµ ÀÖ´Ù. 3-6°³¿ù°£ÀÇ °æ°ú°üÂû¿¡µµ º´º¯ÀÇ È£ÀüÀÌ ´À¸®°Å³ª ÀÏ»ó»ýȰ¿¡ ÁöÀåÀ» ÁÖ´Â ÅëÁõÀ» È£¼ÒÇÏ´Â °æ¿ì ½ºÅ×·ÎÀÌµå ±¹¼Ò ÁÖÀÔ¹ýÀÌ ÁÁÀº Ä¡·á°¡ µÉ ¼ö ÀÖ´Ù.
Purpose: To analyze the clinical features and treatment outcome of Langerhans¡¯ cell histocytosis.

Materials and Methods: From August 1996 to June 2013, 28 patients who histologically proven with LCH were analyzed of medical records, radiography, pathologic character retrospectively.

Results: A total of 28 cases of LCH including 22 child has been reported. Onset age was 0.6 to 51 years old, occurred in the average age was 14.8 years. Follow?up period was 6 months to 134 months average was 44.6 months. The M:F ratio was 2.5:1. The initial symptoms was pain in 18 cases, 5 cases of pathologic fracture, 3 case of palpable mass, 1 case of discovered by accident in radiography, 1 case of torticollis. In radiological examination osteolysis was seen all cases, 7 cases showed a periosteal reaction, 1 case showed soft tissue extension. Clinical type of all cases were eosinophilic granuloma. 25 cases were classified as unifocal disease and 3 cases were multifocal single systemic diseases. In all cases, incisional biopsy was performed. After histologic confirmed, 14 cases was treated with curettage or surgical excision of the lesion and the other 14 cases were followed up without treatment. There is no death during follow up period. 11 cases has no radiological improvement after 3?6 months observation, intralesional steroid injection was performed.

Conclusion: Patients with LCH who has rapid systemic onset is very rare, so if you meet the young children who suspected LCH, you shoulder avoid the examination which cause excessive radiation exposure to the young patient. In order to confirm the diagnosis of disease, biopsy is needed. Close observation after confirmed by histological method will bring the satisfactory results. But the patients who had pathologic fracture or wide bone destruction already may need curettage and bone grafting to lesion or internal fixation. The lesion which has no radiological improvement after 3?6 months observation or appear with pain interferes daily life may need local steroid injection as a good treatment.

Ű¿öµå

¶û°Ô¸£Çѽº ¼¼Æ÷ Á¶Á÷±¸Áõ, ½ºÅ×·ÎÀÌµå ±¹¼Ò ÁÖÀÔ¼ú¿ì±îÁö
Langerhans cell histiocytosis, intralesional steroid injection
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå